CGON
CGON
US1569441009
CG Oncology, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 4.040.000 1.139.000
254.7%
Cost of Revenue 4.647.000 --
--
Gross Profit -607.000 1.139.000
153.3%
190.167.000 115.805.000
64.2%
Operating Income -190.774.000 -114.666.000
66.4%
Pretax Income -160.995.000 -88.039.000
82.9%
Net Income Common Stockholders -160.995.000 -88.039.000
82.9%
-- --
--
-- --
--
ende